VDP PATENT, LLC v. Welch Allyn Holdings, Inc.

623 F. Supp. 2d 414, 2008 U.S. Dist. LEXIS 48758, 2008 WL 2566559
CourtDistrict Court, S.D. New York
DecidedJune 24, 2008
Docket06 Civ. 5821 (GEL)
StatusPublished

This text of 623 F. Supp. 2d 414 (VDP PATENT, LLC v. Welch Allyn Holdings, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
VDP PATENT, LLC v. Welch Allyn Holdings, Inc., 623 F. Supp. 2d 414, 2008 U.S. Dist. LEXIS 48758, 2008 WL 2566559 (S.D.N.Y. 2008).

Opinion

OPINION AND ORDER

GERARD E. LYNCH, District Judge:

Plaintiff VDP Patent, LLC, (‘VDP”) owns a patented method to remove cerumen — earwax—from the ear canal, U.S. Patent No. 5,944,711 (the “'711 patent”). 1 VDP accuses defendants Welch Allyn Holdings, Inc., d/b/a Welch Allyn, Inc., (“Welch Allyn”) a manufacturer of medical equipment, and Harold Ellis Drugs and Surgicals, Inc., a distributor of Welch Allyn’s products, of selling an ear-washing system that infringes the '711 patent.

*419 In a previous round of briefing, defendants moved for partial summary judgment on two grounds: first, that their device does not literally infringe the '711 patent, and second, that their device does not infringe plaintiffs patent under the doctrine of equivalents. By opinion and order dated June 28, 2007, this Court accepted the first argument and rejected the second. See VDP Patent, LLC v. Welch Allyn Holdings, Inc., 623 F.Supp.2d 364 (S.D.N.Y.2007). The Court construed the term “otoscope” as used in the '711 patent’s single claim, holding that an otoscope is not simply an access device but a viewing device as well, and that, in the context of the patent, the term denotes an instrument incorporating a light and lens, used for visual examination of the inner ear. Id. at 367-71. On that basis, the Court granted defendants partial summary judgment on the grounds that their device, which has neither a light nor a lens, does not literally infringe plaintiffs patent. However, the Court rejected defendants’ motion for summary judgment that their device does not infringe plaintiffs patent under the doctrine of equivalents, noting that the issue “presents a question of fact that should not be determined until, at the earliest, after the parties have had an opportunity for further discovery.” Id. at 379.

In its 2007 opinion, the Court construed only one element of the claim — otoscope— noting that “the parties may require a further opportunity to argue in detail the construction of other aspects of the claim.” Id. at 369. Although the parties stipulate to the meaning of some elements of the '711 patent’s claim (see Joint Claim Construction Statement, dated February 19, 2008), they disagree on the meaning of others, and now cross-move for the Court to resolve those disputes. Defendants also move for a finding that the patent is invalid as a matter of law because one particular element — “cylindrical shape in cross[-]section” — -is indefinite.

The various elements at issue are properly construed as set forth below. Because defendants have failed to demonstrate by clear and convincing evidence that “cylindrical shape in cross[-]section” is indefinite, their motion for summary judgment of invalidity must be denied.

BACKGROUND

The background of this case is set forth in more detail in the Court’s previous opinion and order. See 623 F.Supp.2d at 366-67. The finals '711 patent contains only one claim:

A method of irrigating a pat[i]ent’s ear using an otoscope of a type having an operating mode of flushing cerumen therefrom with body temperature water, said method comprising the steps of [providing an otoscope,] 2 configurating a tip of said otoscope in a cylindrical shape in cross[-]section and of a selected outside diameter, selecting a tip outside diameter that is slightly oversized with respect to a diameter of an anatomical opening of said patient’s ear canal, inserting said tip into said ear canal, establishing at a site of engagement of said different diameters of said tip and said ear canal opening a friction fit obviating fluid leakage externally of said site, providing a source of body temperature water and a return sump therefore, and continuously flowing said body temperature water from said source into and removing water and cerumen from said ear of said patient for return to said *420 sump through said tip until the removal of cerumen is completed, whereby a maintained said fluid leakage seal during said continuous flowing of said body temperature water obviates a splattering of said patient.

('711 Patent, col. 4.)

DISCUSSION

I. Legal Standards

A. Claim Construction

Interpretation of a patent claim, which defines a patentee’s rights, is a matter of law reserved entirely for the court. Markman v. Westview Instruments, Inc., 517 U.S. 370, 372, 116 S.Ct. 1384, 134 L.Ed.2d 577 (1996). “Claim construction is a matter of resolution of disputed meanings and technical scope, to clarify and when necessary to explain what the patentee covered by the claims, for use in the determination of infringement.” U.S. Surgical Corp. v. Ethicon, Inc., 103 F.3d 1554, 1568 (Fed.Cir.1997).

1. Intrinsic Evidence

In construing a patent claim, courts must first examine the intrinsic evidence of record: the claim, specification, and prosecution history. Vitronics Corp. v. Conceptronic, Inc., 90 F.3d 1576, 1582 (Fed.Cir.1996). The Court’s task is to construe the meaning .of a disputed term as it is used in the claim. Words in a claim are “generally given their ordinary and customary meaning,” although an inventor “may choose to be his own lexicographer and use terms in a manner other than their ordinary meaning, as long as the special definition of the term is clearly stated in the patent specification or file history.” Id. (citations omitted). Therefore, intrinsic evidence is the “most significant source of the legally operative meaning of disputed claim language.” Id. at 1582. In interpreting the terms of a claim, the first place to look is the language of the claim itself, as “the claims themselves provide substantial guidance as to the meaning of particular claim terms.” Phillips v. AWH Corp., 415 F.3d 1303, 1314 (Fed.Cir.2005) (en banc) (citation and internal quotation marks omitted). “[T]he context of the surrounding words of the claim” can be “highly instructive,” and “must be considered in determining the ordinary and customary meaning of those terms.” Id. Furthermore, since “claim terms are normally used consistently throughout the patent,” the usage of a term in one part of a claim may “illuminate the meaning of the same term” in other parts of the claim. Id. (citations omitted).

As claims are “part of a fully integrated written instrument [citation omitted] consisting principally of a specification that concludes with the claims,” id. at 1315 (citation and internal quotation marks omitted), the specification is “always highly relevant” and “[u]sually ... dispositive,” Vitronics,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

General Electric Co. v. Wabash Appliance Corp.
304 U.S. 364 (Supreme Court, 1938)
United Carbon Co. v. Binney & Smith Co.
317 U.S. 228 (Supreme Court, 1942)
Graver Tank & Mfg. Co. v. Linde Air Products Co.
339 U.S. 605 (Supreme Court, 1950)
Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co.
535 U.S. 722 (Supreme Court, 2002)
Allvoice Computing PLC v. Nuance Communications, Inc.
504 F.3d 1236 (Federal Circuit, 2007)
Daiichi Sankyo Co., Ltd. v. Apotex, Inc.
501 F.3d 1254 (Federal Circuit, 2007)
Abraxis Bioscience, Inc. v. Mayne Pharma (USA) Inc.
467 F.3d 1370 (Federal Circuit, 2006)
Marley Mouldings, Ltd. v. Mikron Industries, Inc.
417 F.3d 1356 (Federal Circuit, 2005)
Datamize, L.L.C. v. Plumtree Software, Inc.
417 F.3d 1342 (Federal Circuit, 2005)
Vitronics Corporation v. Conceptronic, Inc.
90 F.3d 1576 (Federal Circuit, 1996)
Key Pharmaceuticals v. Hercon Laboratories Corporation
161 F.3d 709 (Federal Circuit, 1999)
Sandra Solomon v. Kimberly-Clark Corporation
216 F.3d 1372 (Federal Circuit, 2000)
Exxon Research and Engineering Company v. United States
265 F.3d 1371 (Federal Circuit, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
623 F. Supp. 2d 414, 2008 U.S. Dist. LEXIS 48758, 2008 WL 2566559, Counsel Stack Legal Research, https://law.counselstack.com/opinion/vdp-patent-llc-v-welch-allyn-holdings-inc-nysd-2008.